OqxAB, a quinolone and olaquindox efflux pump, is widely distributed among multidrug-resistant Klebsiella pneumoniae isolates of human origin

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 9, 2013, Pages 4602-4603

  Perez, Federico ^a,b   Rudin, Susan D ^a,b   Marshall, Steven H ^a   Coakley, Peter ^c   Chen, Liang ^d   Kreiswirth, Barry N ^d   Rather, Philip N ^e   Hujer, Andrea M ^b   Toltzis, Philip ^f   Van Duin, David ^g   Paterson, David L ^h   Bonomo, Robert A ^a,b  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; OLAQUINDOX; QUINOLONE;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; CONTROLLED STUDY; KLEBSIELLA PNEUMONIAE; LETTER; LONG TERM CARE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PREVALENCE; PRIORITY JOURNAL;

AMERICAS; ANIMALS; ANTI-BACTERIAL AGENTS; ASIA; AUSTRALIA; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, MDR; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; QUINOLONES; QUINOXALINES; SWINE; SWINE DISEASES;

EID: 84882302963     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00725-13     Document Type: Letter

References (12)

1. Marshall BM, Levy SB. 2011. Food animals and antimicrobials: impacts on human health. Clin. Microbiol. Rev. 24:718-733.
2. Carta A, Corona P, Loriga M. 2005. Quinoxaline 1,4-dioxide: a versatile scaffold endowed with manifold activities. Curr. Med. Chem. 12:2259-2272.
3. Hansen LH, Jensen LB, Sorensen HI, Sorensen SJ. 2007. Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria. J. Antimicrob. Chemother. 60:145-147.
4. Sorensen AH, Hansen LH, Johannesen E, Sorensen SJ. 2003. Conjugative plasmid conferring resistance to olaquindox. Antimicrob. Agents Chemother. 47:798-799.
5. Norman A, Hansen LH, She Q, Sorensen SJ. 2008. Nucleotide sequence of pOLA52: a conjugative IncX1 plasmid from Escherichia coli which enables biofilm formation and multidrug efflux. Plasmid 60:59-74.
6. Wong MH, Chen S. 2013. First detection of oqxAB in Salmonella spp. isolated from food. Antimicrob. Agents Chemother. 57:658-660.
7. Park KS, Kim MH, Park TS, Nam YS, Lee HJ, Suh JT. 2012. Prevalence of the plasmid-mediated quinolone resistance genes, aac(6=)-Ib-cr, qepA, and oqxAB in clinical isolates of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae in Korea. Ann. Clin. Lab. Sci. 42:191-197.
8. Yuan J, Xu X, Guo Q, Zhao X, Ye X, Guo Y, Wang M. 2012. Prevalence of the oqxAB gene complex in Klebsiella pneumoniae and Escherichia coli clinical isolates. J. Antimicrob. Chemother. 67:1655-1659.
9. Rodriguez-Martinez JM, Diaz de Alba P, Briales A, Machuca J, Lossa M, Fernandez-Cuenca F, Rodriguez Bano J, Martinez-Martinez L, Pascual A. 2013. Contribution of OqxAB efflux pumps to quinolone resistance in extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae. J. Antimicrob. Chemother. 68:68-73.
10. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing, CLSI M100-S21. CLSI, Wayne, PA.
11. Viau RA, Hujer AM, Marshall SH, Perez F, Hujer KM, Briceno DF, Dul M, Jacobs MR, Grossberg R, Toltzis P, Bonomo RA. 2012. "Silent" dissemination of Klebsiella pneumoniae isolates bearing K. pneumoniae carbapenemase in a long-term care facility for children and young adults in Northeast Ohio. Clin. Infect. Dis. 54:1314-1321.
12. Paterson DL, Hujer KM, Hujer AM, Yeiser B, Bonomo MD, Rice LB, Bonomo RA. 2003. Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV-and CTX-M-type beta-lactamases. Antimicrob. Agents Chemother. 47:3554-3560.